Elite Wealth Management, Inc. Seagen Inc. Transaction History

Elite Wealth Management, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	SELL	$191.51 - $216.16 $75,837 - $85,599	-396 Reduced 2.73%	14,088 $2.99 Million
Q2 2023 Jul 28, 2023	BUY	$187.64 - $206.25 $1.32 Million - $1.45 Million	7,013 Added 93.87%	14,484 $2.79 Million
Q1 2023 May 04, 2023	BUY	$127.59 - $203.08 $15,565 - $24,775	122 Added 1.66%	7,471 $1.51 Million
Q4 2022 Feb 08, 2023	SELL	$117.37 - $139.17 $2,112 - $2,505	-18 Reduced 0.24%	7,349 $944,000
Q3 2022 Oct 27, 2022	SELL	$135.27 - $180.11 $33,005 - $43,946	-244 Reduced 3.21%	7,367 $1.01 Million
Q2 2022 Jul 27, 2022	SELL	$108.81 - $179.33 $20,021 - $32,996	-184 Reduced 2.36%	7,611 $1.35 Million
Q1 2022 Apr 21, 2022	SELL	$119.61 - $157.85 $4,664 - $6,156	-39 Reduced 0.5%	7,795 $1.12 Million
Q4 2021 Jan 19, 2022	SELL	$142.57 - $190.86 $70,572 - $94,475	-495 Reduced 5.94%	7,834 $1.21 Million
Q3 2021 Oct 15, 2021	SELL	$142.45 - $169.82 $22,507 - $26,831	-158 Reduced 1.86%	8,329 $1.41 Million
Q2 2021 Aug 06, 2021	BUY	$135.08 - $161.1 $99,283 - $118,408	735 Added 9.48%	8,487 $1.34 Million
Q1 2021 May 04, 2021	BUY	$137.51 - $190.8 $329,473 - $457,156	2,396 Added 44.73%	7,752 $1.08 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $881,758 - $1.14 Million	5,356 New	5,356 $938,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Elite Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Elite Wealth Management, Inc. with notifications on news.